Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biomolecular Markers of Bone Metastasis
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Summary
The goal of this clinical trial is to characterize the biomolecular profile of bone metastases to define the predisposing profiles of bone metastasis, in patients with breast or lung or renal carcinomas or of the gastroenteric or prostate tract with bone metastasis. The main question it aims to answer is: Is it possible to predict the progression of bone metastasis by identifying biomarkers as risk factors for bone metastasis?
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2024-09-17
Completion Date
2026-09-17
Last Updated
2025-02-04
Healthy Volunteers
No
Conditions
Interventions
Biomolecular profile of bone metastases
Describe the biomolecular profile of bone metastases
Locations (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy